HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urinary diversion in children with pelvic tumors.

AbstractPURPOSE:
The aim of this study was to investigate children presenting with malignant pelvic tumors obstructing the upper urinary tract.
METHODS:
Seventeen children with upper urinary tract obstruction by a malignant tumor were reviewed. A nephrostomy tube or Double J (DJ) stent was inserted into each obstructed urinary system and removed after tumor shrinkage and/or hydronephrosis regression.
RESULTS:
There were 9 boys and 8 girls in the study; the mean age and median follow-up were 5.7 years and 2.5 years, respectively. The most common obstructing tumor was rhabdomyosarcoma. Twelve children underwent diversion by nephrostomy tubes and 3 by DJ stents; 2 patients underwent resection of the tumors with ureteroureterostomy. Complications after the insertion of the stents included febrile urinary tract infections (UTI) or pyelonephritis in 4 of the children with DJ stents. In the nephrostomy group, febrile UTI developed in 3 and the tube fell out in 1, and was blocked in another. Of the 17 children, 9 have no evidence of disease, 2 are currently under treatment, and 6 died of cancer.
CONCLUSIONS:
The prognosis of children with malignant pelvic tumor obstructing the upper urinary system justifies urgent and optimal upper tract diversion, enabling chemotherapy to be started immediately.
AuthorsD Ben Meir, M Inoue, U Gur, P M Livne, Y Yaniv, K Tiedeman, D M Ashley, J M Hutson
JournalJournal of pediatric surgery (J Pediatr Surg) Vol. 39 Issue 12 Pg. 1787-90 (Dec 2004) ISSN: 1531-5037 [Electronic] United States
PMID15616930 (Publication Type: Journal Article)
Topics
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Pelvic Neoplasms (complications)
  • Ureteral Obstruction (etiology, surgery)
  • Urinary Diversion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: